Stellar Biotechnologies, Inc.
Stellar Biotechnologies, Inc. (SBOT) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 15 transactions totaling $47.3K, demonstrating a bearish sentiment with -$47.3K in net insider flow. The most recent transaction on Mar 6, 2019 involved a sale of 4,000 shares valued at $5.0K.
SBOT Insider Activity Summary
Who Is Buying SBOT Stock?
No significant insider buying has been recorded for SBOT in the recent period.
Who Is Selling SBOT Stock?
No significant insider selling has been recorded for SBOT in the recent period.
Is Stellar Biotechnologies, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SBOT is bearish with an Insider Alignment Score of 0/100 and a net flow of -$47.3K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
SBOT Frequently Asked Questions
Understanding SBOT Insider Activity
Insider trading at Stellar Biotechnologies, Inc. (SBOT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading SBOT stock, having executed 15 transactions in the past 90 days. The most active insider is Frank R. Oakes (Executive), who has made 7 transactions totaling $395.4K.
Related Tools
Track Stellar Biotechnologies, Inc. Insider Activity
Get notified when executives and directors at SBOT file new Form 4 transactions